Redirect Notice
 The previous page is sending you to https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fjpn01.safelinks.protection.outlook.com%2F%3Furl%3Dhttps%253A%252F%252Fwww.ema.europa.eu%252Fen%252Fmedicines%252Fhuman%252FEPAR%252Fpoteligeo%2523product-information-section%26data%3D04%257C01%257CRichard.Oakley%2540kyowakirin.com%257C161250a984534346a3a508d920f98486%257C34db9a5d91ba486ebb82d37d2ee1d84c%257C0%257C0%257C637577078322676853%257CUnknown%257CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%257C1000%26sdata%3DK6mnITH%252FrCwPStRdaSgm7%252BNiwnXVsNdzfcCBbWg0lLo%253D%26reserved%3D0&esheet=52509125&newsitemid=20211014005442&lan=en-US&anchor=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fmedicines%2Fhuman%2FEPAR%2Fpoteligeo%23product-information-section&index=1&md5=2867bcabd3de209ba8385df333c823b9.

 If you do not want to visit that page, you can return to the previous page.